Cargando…
Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People’s Republic of China
BACKGROUND: The aims of this analysis were to identify factors associated with early response (at 4 weeks) to olanzapine treatment and to assess whether early response is associated with better longer-term outcomes for patients with schizophrenia in the People’s Republic of China. METHODS: A post ho...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037300/ https://www.ncbi.nlm.nih.gov/pubmed/24876779 http://dx.doi.org/10.2147/NDT.S59468 |
_version_ | 1782318236971302912 |
---|---|
author | Ye, Wenyu Montgomery, William Kadziola, Zbigniew Liu, Li Xue, Haibo Stensland, Michael D Treuer, Tamas |
author_facet | Ye, Wenyu Montgomery, William Kadziola, Zbigniew Liu, Li Xue, Haibo Stensland, Michael D Treuer, Tamas |
author_sort | Ye, Wenyu |
collection | PubMed |
description | BACKGROUND: The aims of this analysis were to identify factors associated with early response (at 4 weeks) to olanzapine treatment and to assess whether early response is associated with better longer-term outcomes for patients with schizophrenia in the People’s Republic of China. METHODS: A post hoc analysis of a multi-country, 6-month, prospective, observational study of outpatients with schizophrenia or bipolar mania who initiated or switched to treatment with oral olanzapine was conducted using data from the Chinese schizophrenia subgroup (n=330). Factors associated with early response were identified using a stepwise logistic regression with baseline clinical characteristics, baseline participation in a weight control program, and adherence with antipsychotics during the first 4 weeks of treatment. Mixed models for repeated measures with baseline covariates were used to compare outcomes over time between early responders and early nonresponders to olanzapine. RESULTS: One hundred and thirty patients (40%) achieved an early response. Early response was independently predicted by higher baseline Clinical Global Impressions-Severity score (odds ratio [OR] 1.51, 95% confidence interval [CI] 1.15–1.97), fewer years since first diagnosis (OR 0.94, CI 0.90–0.98), a greater number of social activities (OR 1.22, CI 1.05–1.40), participation in a weight control program (OR 1.81, CI 1.04–3.15), and high adherence with antipsychotics during the first 4 weeks of treatment (OR 2.98, CI 1.59–5.58). Relative to early nonresponders, early responders were significantly more likely to meet treatment response criteria at endpoint, had significantly greater symptom improvement (Clinical Global Impressions-Severity), and had significantly greater improvement in functional outcomes (all P<0.05). CONCLUSION: High levels of adherence to prescribed antipsychotics and participation in a weight control program were associated with early response to olanzapine in Chinese patients with schizophrenia. Early response was associated with greater improvement in symptomatic, functional, and quality of life outcomes at 6 months compared with early nonresponse. Current findings are consistent with previous research outside of the People’s Republic of China. |
format | Online Article Text |
id | pubmed-4037300 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-40373002014-05-29 Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People’s Republic of China Ye, Wenyu Montgomery, William Kadziola, Zbigniew Liu, Li Xue, Haibo Stensland, Michael D Treuer, Tamas Neuropsychiatr Dis Treat Original Research BACKGROUND: The aims of this analysis were to identify factors associated with early response (at 4 weeks) to olanzapine treatment and to assess whether early response is associated with better longer-term outcomes for patients with schizophrenia in the People’s Republic of China. METHODS: A post hoc analysis of a multi-country, 6-month, prospective, observational study of outpatients with schizophrenia or bipolar mania who initiated or switched to treatment with oral olanzapine was conducted using data from the Chinese schizophrenia subgroup (n=330). Factors associated with early response were identified using a stepwise logistic regression with baseline clinical characteristics, baseline participation in a weight control program, and adherence with antipsychotics during the first 4 weeks of treatment. Mixed models for repeated measures with baseline covariates were used to compare outcomes over time between early responders and early nonresponders to olanzapine. RESULTS: One hundred and thirty patients (40%) achieved an early response. Early response was independently predicted by higher baseline Clinical Global Impressions-Severity score (odds ratio [OR] 1.51, 95% confidence interval [CI] 1.15–1.97), fewer years since first diagnosis (OR 0.94, CI 0.90–0.98), a greater number of social activities (OR 1.22, CI 1.05–1.40), participation in a weight control program (OR 1.81, CI 1.04–3.15), and high adherence with antipsychotics during the first 4 weeks of treatment (OR 2.98, CI 1.59–5.58). Relative to early nonresponders, early responders were significantly more likely to meet treatment response criteria at endpoint, had significantly greater symptom improvement (Clinical Global Impressions-Severity), and had significantly greater improvement in functional outcomes (all P<0.05). CONCLUSION: High levels of adherence to prescribed antipsychotics and participation in a weight control program were associated with early response to olanzapine in Chinese patients with schizophrenia. Early response was associated with greater improvement in symptomatic, functional, and quality of life outcomes at 6 months compared with early nonresponse. Current findings are consistent with previous research outside of the People’s Republic of China. Dove Medical Press 2014-05-16 /pmc/articles/PMC4037300/ /pubmed/24876779 http://dx.doi.org/10.2147/NDT.S59468 Text en © 2014 Ye et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Ye, Wenyu Montgomery, William Kadziola, Zbigniew Liu, Li Xue, Haibo Stensland, Michael D Treuer, Tamas Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People’s Republic of China |
title | Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People’s Republic of China |
title_full | Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People’s Republic of China |
title_fullStr | Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People’s Republic of China |
title_full_unstemmed | Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People’s Republic of China |
title_short | Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People’s Republic of China |
title_sort | factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the people’s republic of china |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037300/ https://www.ncbi.nlm.nih.gov/pubmed/24876779 http://dx.doi.org/10.2147/NDT.S59468 |
work_keys_str_mv | AT yewenyu factorsassociatedwithearlyresponsetoolanzapineandclinicalandfunctionaloutcomesofearlyresponderstreatedforschizophreniainthepeoplesrepublicofchina AT montgomerywilliam factorsassociatedwithearlyresponsetoolanzapineandclinicalandfunctionaloutcomesofearlyresponderstreatedforschizophreniainthepeoplesrepublicofchina AT kadziolazbigniew factorsassociatedwithearlyresponsetoolanzapineandclinicalandfunctionaloutcomesofearlyresponderstreatedforschizophreniainthepeoplesrepublicofchina AT liuli factorsassociatedwithearlyresponsetoolanzapineandclinicalandfunctionaloutcomesofearlyresponderstreatedforschizophreniainthepeoplesrepublicofchina AT xuehaibo factorsassociatedwithearlyresponsetoolanzapineandclinicalandfunctionaloutcomesofearlyresponderstreatedforschizophreniainthepeoplesrepublicofchina AT stenslandmichaeld factorsassociatedwithearlyresponsetoolanzapineandclinicalandfunctionaloutcomesofearlyresponderstreatedforschizophreniainthepeoplesrepublicofchina AT treuertamas factorsassociatedwithearlyresponsetoolanzapineandclinicalandfunctionaloutcomesofearlyresponderstreatedforschizophreniainthepeoplesrepublicofchina |